Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid – method comparison and round robin study

Brit Mollenhauer, Frederick Du Bois Bowman, Daniel Drake, Jimmy Duong, Kaj Blennow, Omar Ali El-Agnaf, Leslie M. Shaw, Jennifer Masucci, Peggy Taylor, Robert M. Umek, Jill M. Dunty, Chris L. Smith, Erik Stoops, Hugo Vanderstichele, Adrian W. Schmid, Marc Moniatte, Jing Zhang, Niels Kruse, Hilal A. Lashuel, Charlotte TeunissenTanja Schubert, Kuldip D. Dave, Samantha J. Hutten, Henrik Zetterberg

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

α-Synuclein is the major component of Lewy bodies and a candidate biomarker for neurodegenerative diseases in which Lewy bodies are common, including Parkinson's disease and dementia with Lewy bodies. A large body of literature suggests that these disorders are characterized by reduced concentrations of α-synuclein in cerebrospinal fluid (CSF), with overlapping concentrations compared to healthy controls and variability across studies. Several reasons can account for this variability, including technical ones, such as inter-assay and inter-laboratory variation (reproducibility). We compared four immunochemical methods for the quantification of α-synuclein concentration in 50 unique CSF samples. All methods were designed to capture most of the existing α-synuclein forms in CSF (‘total’ α-synuclein). Each of the four methods showed high analytical precision, excellent correlation between laboratories (R2 0.83–0.99), and good correlation with each other (R2 0.64–0.93), although the slopes of the regression lines were different between the four immunoassays. The use of common reference CSF samples decreased the differences in α-synuclein concentration between detection methods and technologies. Pilot data on an immunoprecipitation mass spectrometry (IP-MS) method is also presented. Our results suggest that the four immunochemical methods and the IP-MS method measure similar forms of α-synuclein and that a common reference material would allow harmonization of results between immunoassays. (Figure presented.).

Original languageEnglish
JournalJournal of Neurochemistry
DOIs
Publication statusAccepted/In press - 1 Jan 2018

Fingerprint

Synucleins
Cerebrospinal fluid
Songbirds
Cerebrospinal Fluid
Antibodies
Lewy Bodies
Immunoassay
Immunoprecipitation
Mass spectrometry
Mass Spectrometry
Neurodegenerative diseases
Lewy Body Disease
Biomarkers
Neurodegenerative Diseases
Parkinson Disease
Assays
Technology

Keywords

  • biomarker
  • cerebrospinal fluid
  • enzyme-linked immunoabsorbent assay
  • mass spectrometry
  • round robin
  • α-synuclein

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid – method comparison and round robin study. / Mollenhauer, Brit; Bowman, Frederick Du Bois; Drake, Daniel; Duong, Jimmy; Blennow, Kaj; Ali El-Agnaf, Omar; Shaw, Leslie M.; Masucci, Jennifer; Taylor, Peggy; Umek, Robert M.; Dunty, Jill M.; Smith, Chris L.; Stoops, Erik; Vanderstichele, Hugo; Schmid, Adrian W.; Moniatte, Marc; Zhang, Jing; Kruse, Niels; Lashuel, Hilal A.; Teunissen, Charlotte; Schubert, Tanja; Dave, Kuldip D.; Hutten, Samantha J.; Zetterberg, Henrik.

In: Journal of Neurochemistry, 01.01.2018.

Research output: Contribution to journalArticle

Mollenhauer, B, Bowman, FDB, Drake, D, Duong, J, Blennow, K, Ali El-Agnaf, O, Shaw, LM, Masucci, J, Taylor, P, Umek, RM, Dunty, JM, Smith, CL, Stoops, E, Vanderstichele, H, Schmid, AW, Moniatte, M, Zhang, J, Kruse, N, Lashuel, HA, Teunissen, C, Schubert, T, Dave, KD, Hutten, SJ & Zetterberg, H 2018, 'Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid – method comparison and round robin study', Journal of Neurochemistry. https://doi.org/10.1111/jnc.14569
Mollenhauer, Brit ; Bowman, Frederick Du Bois ; Drake, Daniel ; Duong, Jimmy ; Blennow, Kaj ; Ali El-Agnaf, Omar ; Shaw, Leslie M. ; Masucci, Jennifer ; Taylor, Peggy ; Umek, Robert M. ; Dunty, Jill M. ; Smith, Chris L. ; Stoops, Erik ; Vanderstichele, Hugo ; Schmid, Adrian W. ; Moniatte, Marc ; Zhang, Jing ; Kruse, Niels ; Lashuel, Hilal A. ; Teunissen, Charlotte ; Schubert, Tanja ; Dave, Kuldip D. ; Hutten, Samantha J. ; Zetterberg, Henrik. / Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid – method comparison and round robin study. In: Journal of Neurochemistry. 2018.
@article{1f1b518e4c8648b5b783e89f2fc3509f,
title = "Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid – method comparison and round robin study",
abstract = "α-Synuclein is the major component of Lewy bodies and a candidate biomarker for neurodegenerative diseases in which Lewy bodies are common, including Parkinson's disease and dementia with Lewy bodies. A large body of literature suggests that these disorders are characterized by reduced concentrations of α-synuclein in cerebrospinal fluid (CSF), with overlapping concentrations compared to healthy controls and variability across studies. Several reasons can account for this variability, including technical ones, such as inter-assay and inter-laboratory variation (reproducibility). We compared four immunochemical methods for the quantification of α-synuclein concentration in 50 unique CSF samples. All methods were designed to capture most of the existing α-synuclein forms in CSF (‘total’ α-synuclein). Each of the four methods showed high analytical precision, excellent correlation between laboratories (R2 0.83–0.99), and good correlation with each other (R2 0.64–0.93), although the slopes of the regression lines were different between the four immunoassays. The use of common reference CSF samples decreased the differences in α-synuclein concentration between detection methods and technologies. Pilot data on an immunoprecipitation mass spectrometry (IP-MS) method is also presented. Our results suggest that the four immunochemical methods and the IP-MS method measure similar forms of α-synuclein and that a common reference material would allow harmonization of results between immunoassays. (Figure presented.).",
keywords = "biomarker, cerebrospinal fluid, enzyme-linked immunoabsorbent assay, mass spectrometry, round robin, α-synuclein",
author = "Brit Mollenhauer and Bowman, {Frederick Du Bois} and Daniel Drake and Jimmy Duong and Kaj Blennow and {Ali El-Agnaf}, Omar and Shaw, {Leslie M.} and Jennifer Masucci and Peggy Taylor and Umek, {Robert M.} and Dunty, {Jill M.} and Smith, {Chris L.} and Erik Stoops and Hugo Vanderstichele and Schmid, {Adrian W.} and Marc Moniatte and Jing Zhang and Niels Kruse and Lashuel, {Hilal A.} and Charlotte Teunissen and Tanja Schubert and Dave, {Kuldip D.} and Hutten, {Samantha J.} and Henrik Zetterberg",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/jnc.14569",
language = "English",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid – method comparison and round robin study

AU - Mollenhauer, Brit

AU - Bowman, Frederick Du Bois

AU - Drake, Daniel

AU - Duong, Jimmy

AU - Blennow, Kaj

AU - Ali El-Agnaf, Omar

AU - Shaw, Leslie M.

AU - Masucci, Jennifer

AU - Taylor, Peggy

AU - Umek, Robert M.

AU - Dunty, Jill M.

AU - Smith, Chris L.

AU - Stoops, Erik

AU - Vanderstichele, Hugo

AU - Schmid, Adrian W.

AU - Moniatte, Marc

AU - Zhang, Jing

AU - Kruse, Niels

AU - Lashuel, Hilal A.

AU - Teunissen, Charlotte

AU - Schubert, Tanja

AU - Dave, Kuldip D.

AU - Hutten, Samantha J.

AU - Zetterberg, Henrik

PY - 2018/1/1

Y1 - 2018/1/1

N2 - α-Synuclein is the major component of Lewy bodies and a candidate biomarker for neurodegenerative diseases in which Lewy bodies are common, including Parkinson's disease and dementia with Lewy bodies. A large body of literature suggests that these disorders are characterized by reduced concentrations of α-synuclein in cerebrospinal fluid (CSF), with overlapping concentrations compared to healthy controls and variability across studies. Several reasons can account for this variability, including technical ones, such as inter-assay and inter-laboratory variation (reproducibility). We compared four immunochemical methods for the quantification of α-synuclein concentration in 50 unique CSF samples. All methods were designed to capture most of the existing α-synuclein forms in CSF (‘total’ α-synuclein). Each of the four methods showed high analytical precision, excellent correlation between laboratories (R2 0.83–0.99), and good correlation with each other (R2 0.64–0.93), although the slopes of the regression lines were different between the four immunoassays. The use of common reference CSF samples decreased the differences in α-synuclein concentration between detection methods and technologies. Pilot data on an immunoprecipitation mass spectrometry (IP-MS) method is also presented. Our results suggest that the four immunochemical methods and the IP-MS method measure similar forms of α-synuclein and that a common reference material would allow harmonization of results between immunoassays. (Figure presented.).

AB - α-Synuclein is the major component of Lewy bodies and a candidate biomarker for neurodegenerative diseases in which Lewy bodies are common, including Parkinson's disease and dementia with Lewy bodies. A large body of literature suggests that these disorders are characterized by reduced concentrations of α-synuclein in cerebrospinal fluid (CSF), with overlapping concentrations compared to healthy controls and variability across studies. Several reasons can account for this variability, including technical ones, such as inter-assay and inter-laboratory variation (reproducibility). We compared four immunochemical methods for the quantification of α-synuclein concentration in 50 unique CSF samples. All methods were designed to capture most of the existing α-synuclein forms in CSF (‘total’ α-synuclein). Each of the four methods showed high analytical precision, excellent correlation between laboratories (R2 0.83–0.99), and good correlation with each other (R2 0.64–0.93), although the slopes of the regression lines were different between the four immunoassays. The use of common reference CSF samples decreased the differences in α-synuclein concentration between detection methods and technologies. Pilot data on an immunoprecipitation mass spectrometry (IP-MS) method is also presented. Our results suggest that the four immunochemical methods and the IP-MS method measure similar forms of α-synuclein and that a common reference material would allow harmonization of results between immunoassays. (Figure presented.).

KW - biomarker

KW - cerebrospinal fluid

KW - enzyme-linked immunoabsorbent assay

KW - mass spectrometry

KW - round robin

KW - α-synuclein

UR - http://www.scopus.com/inward/record.url?scp=85056398164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056398164&partnerID=8YFLogxK

U2 - 10.1111/jnc.14569

DO - 10.1111/jnc.14569

M3 - Article

AN - SCOPUS:85056398164

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

ER -